Clinical trial

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

NCT04711915

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-03-17

PhasePHASE1

Study timeline

Study start (actual)2021-03-17Date precision: day

Registry last updated2025-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Depressionunresolved

Interventions

0.1 mg/kg Dimethyltryptamine (DMT)DRUG

0.3 mg/kg Dimethyltryptamine (DMT)DRUG

Sponsors & collaborators

Yale Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04711915 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.